In the USA and Europe, the prevalence of<unk>  ranges from low of 10,000 per 100,000 persons to high of 20,000 per 100,000 people. In Asia, the prevalence of<unk>  is 5,000 per 100,000 people. In the USA, the incidence of<unk>  is 5,400 per 100,000 persons. In Europe, the incidence of<unk>  is 840 per 100,000 persons.The prevalence of<unk>  increases with age. Men and women are affected equally by<unk> . There is no racial predilection for<unk> .
Esophagitis epidemiology and demographics
Achalasia epidemiology and demographics
Laryngitis epidemiology and demographics
Esophageal cancer epidemiology and demographics
Barrett's esophagus epidemiology and demographics
Eosinophilic esophagitis epidemiology and demographics
Pharyngitis epidemiology and demographics
Hypopharyngeal cancer epidemiology and demographics